400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Metabolic Enzyme / IDH / Mutant IDH1-IN-1
CAS No.: 1355326-21-4
Mutant IDH1-IN-1 is a potent mutant IDH1 R132H inhibitor with IC50 < 0.1 μM.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT03718767 | Glioma Gliobl... more >>astoma High Grage Glioma Low Grade Glioma Malignant Glioma Collapse << | Phase 2 | Not yet recruiting | December 31, 2022 | United States, Maryland ... more >> National Institutes of Health Clinical Center Not yet recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 Collapse << |
NCT03684811 | Cohort 1a and 1b: Glioma ... more >> Cohort 1a and 1b: Glioblastoma Multiforme Cohort 2a and 2b: Hepatobiliary Tumors (Hepatocellular Carcinoma, Bile Duct Carcinoma, Intrahepatic Cholangiocarcinoma, Other Hepatobiliary Carcinomas) Cohort 3a and 3b: Chondrosarcoma Cohort 4a and 4b: Intrahepatic Cholangiocarcinoma Cohort 5a: Other Solid Tumors With IDH1 Mutations Collapse << | Phase 1 Phase 2 | Recruiting | April 1, 2022 | United States, Florida ... more >> University of Miami, Sylvester Comprehensive Cancer Center Recruiting Miami, Florida, United States, 33136 Contact: Tamara Leon 305-243-0865 txl351@med.miami.edu Collapse << |
NCT03499912 | - | - | Recruiting | July 1, 2019 | Taiwan ... more >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Wen-Chien Chou 0972651701 wchou@ntu.edu.tw Collapse << |
实验方案
技术信息
CAS号 | 1355326-21-4 | 储存条件 |
|
|
分子式 | C30H31FN4O2 | 运输 | 蓝冰 | |
分子量 | 498.59 | 别名 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT03718767 | Glioma Gliobl... more >>astoma High Grage Glioma Low Grade Glioma Malignant Glioma Collapse << | Phase 2 | Not yet recruiting | December 31, 2022 | United States, Maryland ... more >> National Institutes of Health Clinical Center Not yet recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 Collapse << |
NCT03684811 | Cohort 1a and 1b: Glioma ... more >> Cohort 1a and 1b: Glioblastoma Multiforme Cohort 2a and 2b: Hepatobiliary Tumors (Hepatocellular Carcinoma, Bile Duct Carcinoma, Intrahepatic Cholangiocarcinoma, Other Hepatobiliary Carcinomas) Cohort 3a and 3b: Chondrosarcoma Cohort 4a and 4b: Intrahepatic Cholangiocarcinoma Cohort 5a: Other Solid Tumors With IDH1 Mutations Collapse << | Phase 1 Phase 2 | Recruiting | April 1, 2022 | United States, Florida ... more >> University of Miami, Sylvester Comprehensive Cancer Center Recruiting Miami, Florida, United States, 33136 Contact: Tamara Leon 305-243-0865 txl351@med.miami.edu Collapse << |
NCT03499912 | - | - | Recruiting | July 1, 2019 | Taiwan ... more >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Wen-Chien Chou 0972651701 wchou@ntu.edu.tw Collapse << |
NCT02677922 | Leukemia, Myeloid, Acute | Phase 1 Phase 2 | Active, not recruiting | January 28, 2019 | - |
NCT03666559 | Recurrent IDH1/2 Mutated Gliom... more >>a Collapse << | Phase 2 | Not yet recruiting | April 2022 | France ... more >> Pitie Salpetriere Hospital Paris, France, 75013 Collapse << |
NCT03471260 | Other Diseases of Blood and Bl... more >>ood-forming Organs Advanced Hematologic Malignancies Acute Myeloid Leukemia Collapse << | Phase 1 Phase 2 | Recruiting | September 2019 | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact cdinardo@mdanderson.org Collapse << |
NCT02826642 | Acute Myeloid Leukemia (AML) | Phase 1 | Withdrawn | November 29, 2016 | - |
NCT03343197 | Glioma | Phase 1 | Recruiting | September 1, 2020 | United States, California ... more >> United States, California Recruiting Los Angeles, California, United States, 90024 United States, California Recruiting San Francisco, California, United States, 94143 United States, Massachusetts United States, Massachusetts Recruiting Boston, Massachusetts, United States, 02215 United States, New York United States, New York Recruiting New York, New York, United States, 10065 United States, North Carolina United States, North Carolina Recruiting Durham, North Carolina, United States, 27710 United States, Texas United States, Texas Recruiting Dallas, Texas, United States, 75390 Collapse << |
NCT03749187 | Glioblastoma ... more >>IDH1 Gene Mutation IDH2 Gene Mutation Low Grade Glioma Malignant Glioma Recurrent Glioblastoma Recurrent WHO Grade II Glioma Recurrent WHO Grade III Glioma WHO Grade II Glioma WHO Grade III Glioma Collapse << | Phase 1 | Not yet recruiting | July 2027 | - |
NCT03564821 | IDH1 Mutation Myeloid Neoplasm... more >>s Collapse << | Phase 1 | Not yet recruiting | July 31, 2024 | United States, Massachusetts ... more >> Massachusetts General Hospital Not yet recruiting Boston, Massachusetts, United States, 02214 Contact: Amir T Fathi, MD 617-724-4000 afathi@partners.org Principal Investigator: Amir T Fathi, MD Collapse << |
NCT02977689 | Glioma | Phase 2 | Withdrawn(Novartis paused all ... more >>study start-up activities due to safety evaluation of IDH305 compound.) Collapse << | April 2020 | United States, New York ... more >> Laura & Isaac Perlmutter Cancer Center & NYU Langone Medical Center New York, New York, United States, 10016 Collapse << |
NCT02746081 | Solid Tumors | Phase 1 | Active, not recruiting | June 3, 2019 | United States, California ... more >> Los Angeles, California, United States, 90033 Santa Monica, California, United States, 90403 United States, Texas Houston, Texas, United States, 77030 United States, Virginia Charlottesville, Virginia, United States, 22908 Denmark Copenhagen, Denmark, 2100 Germany Heidelberg, Baden-Württemberg, Germany, 69120 Tübingen, Baden-Württemberg, Germany, 72076 München, Bayern, Germany, 81377 Frankfurt, Hessen, Germany, 60596 Essen, Nordrhein-Westfalen, Germany, 45147 Japan Nagoya, Aichi, Japan, 466-8560 Kashiwa-shi, Chiba, Japan, 277-8577 Chuo-ku, Tokyo, Japan, 104-0045 Collapse << |
NCT03127735 | Leukemia, Myeloid, Acute | Phase 1 | Active, not recruiting | October 11, 2019 | United States, California ... more >> University of Southern California Keck School of Medicine Los Angeles, California, United States, 90033-9172 United States, Florida University of Florida-Gainesville Gainesville, Florida, United States, 32608 United States, Georgia Northside Hospital - Atlanta Atlanta, Georgia, United States, 30342 United States, Illinois Northwestern Memorial Hospital Chicago, Illinois, United States, 60611-2908 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467-2490 Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Mount Sinai Medical Center New York, New York, United States, 10029 United States, North Carolina Wake Forest Baptist Health Winston-Salem, North Carolina, United States, 27157 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Germany Universitätsklinikum Heidelberg Heidelberg, Baden-Württemberg, Germany, 69120 Klinikum rechts der Isar München, Bayern, Germany, 81675 Medizinische Hochschule Hannover (MHH) Hannover, Niedersachsen, Germany, 30625 Universitätsklinikum Essen Essen, Nordrhein-Westfalen, Germany, 45122 Universitätsklinikum Leipzig AöR Leipzig, Sachsen, Germany Universitätsklinikum Charite zu Berlin Berlin, Germany, 12200 Universitätsklinikum Hamburg Eppendorf (UKE) Hamburg, Germany, 20246 Collapse << |
NCT03212274 | Advanced Malignant Solid Neopl... more >>asm Glioblastoma IDH1 Gene Mutation IDH2 Gene Mutation Recurrent Cholangiocarcinoma Recurrent Glioma Recurrent Malignant Solid Neoplasm WHO Grade II Glioma WHO Grade III Glioma Collapse << | Phase 2 | Suspended(Other - null) | July 31, 2019 | United States, California ... more >> University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 United States, Connecticut Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States, 06510 Yale University New Haven, Connecticut, United States, 06520 United States, District of Columbia MedStar Georgetown University Hospital Washington, District of Columbia, United States, 20007 United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Massachusetts Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Ohio Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 United States, Pennsylvania University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网